A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 38/00 (2006.01) A61P 9/00 (2006.01) A61P 9/04 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2582143
A pharmaceutical for treatment of acute myocardial infarction (AMI), idiopathic cardiomyopathy (ICM), dilated cardiomyopathy (DCM) or cardiac failure, administered in the joint use of ventricular assist device (VAD), which pharmaceutical comprises a gene coding for angiogenesis cytokine.
La présente invention a pour objet un médicament pour le traitement d'infarctus du myocarde aigu (IMA), de myocardiopathie idiopathique (MCI), de myocardiopathie dilatée (MCD) ou d'insuffisances cardiaques. Ledit médicament est administré conjointement à l'utilisation d'un dispositif d'assistance ventriculaire (DAV) et comprend un gène codant pour une cytokine angiogénétique.
Matsuda Hikaru
Sawa Yoshiki
Shirakawa Yukitoshi
Taenaka Yoshiyuki
Tatsumi Eisuke
Anges Mg Inc.
Sawa Yoshiki
Smart & Biggar
LandOfFree
Gene therapy for treatment of heart failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene therapy for treatment of heart failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene therapy for treatment of heart failure will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1828327